Produktinformation
Name:
Verdinexor
Beschreibung:
Verdinexor is an antibody-based therapeutic that targets the fatty acid binding protein (FABP) receptor, which is expressed at high levels in cancer cells. It has been shown to inhibit the proliferation of cervical cancer cells and induce apoptosis. Verdinexor also binds to epidermal growth factor and prevents its interaction with the FABP receptor. This drug has minimal toxicity and can be administered intravenously or subcutaneously, making it a promising therapeutic for patients with hematopoietic cancers.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
442.32 g/mol
Formel:
C18H12F6N6O
Reinheit:
Min. 95%
InChl:
InChI=1S/C18H12F6N6O/c19-17(20,21)12-7-11(8-13(9-12)18(22,23)24)16-26-10-30(29-16)6-4-15(31)28-27-14-3-1-2-5-25-14/h1-10H,(H,25,27)(H,28,31)/b6-4-
InChI Key:
InChIKey=OPAKEJZFFCECPN-XQRVVYSFSA-N
SMILES:
O=C(/C=C\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1ccccn1
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
